Thats a damn good possibility.. the most important thing is that they are a publicly trader company.. with all this revenue and attention pouring in now they are quickly becoming a world class biotech company and every facet of the company needs to reflect that.. thats why i am very very confident that news and filings are going to begin flowing here.. this is turning into two things. 1) A major candidate to upist to an exchange like NASDAQ. 2) A prime buyout target by a multi billion dollar competitor. Either way this is heading to the big time!
News 
Market Data 
Discover 
AI
